PARIS (Agefi-Dow Jones)–The Parisian equity market should open higher on Monday, continuing to benefit, at the start of the week on the light agenda, from signs of easing inflation in the United States which are fueling renewed optimism about the prospects for the world’s largest economy.
Around 8:30 a.m., the futures contract on the CAC 40 index gained 27.8 points, or 0.4%, according to data from broker IG.
The New York Stock Exchange ended higher on Friday as investors hoped the Federal Reserve (Fed) would be less inclined to raise rates sharply after inflation decelerated in July. The Dow Jones index rose 1.3%, the S&P 500 gained 1.7%, and the Nasdaq Composite ended the session with a gain of 2.1%.
The slowdown in inflation in the United States in July has “fuelled hopes that things will improve in the second half”, but “it is still too early to uncork the champagne and announce the end of the market downturn” , tempers Ipek Ozkardeskaya, analyst at Swissquote.
On the business side, the biotechnology company Valneva has filed with the Securities and Exchange Commission (SEC), the policeman of the American stock market, an additional prospectus preliminary to an equity financing program.
Under this program, the company may issue to eligible investors a total gross amount of up to $75 million, or €73.2 million, in the form of American Depositary Shares (“ADS”). ), each of those U.S. certificates of deposit representing two common shares of the company, Valneva said.
The pharmaceutical company Ipsen announced on Friday evening that it had completed the acquisition of Epizyme, an American biopharmaceutical company specializing in oncology. Ipsen had announced this operation at the end of June for an initial amount estimated at 247 million dollars (234 million euros).
-Alice Doré, Agefi-Dow Jones; +33 (0)1 41 27 47 90; [email protected] ed: LBO
Agefi-Dow Jones The financial newswire
Dow Jones Newswires
August 15, 2022 02:42 ET (06:42 GMT)